These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent. Author: Rosenthale ME, Begany AJ, Dervinis A, Sellstedt J, Guinosso C, Gluckman MI. Journal: J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988. Abstract: In a series of tests designed to illustrate immune reactions similar to those obtained in atopic disease, Wy-16,922 effectively inhibited reaginic-mediated immunologic reactions in the skin, lungs and mast cell. It was found to be devoid of immunosuppressant, antimediator, anti-inflammatory, steroid or bronchodilator properties as well as acute toxicity. Although the mechanism of action of Wy-16,922 is unknown, it appears to limit the release (not the effects) of allergic mediators in a manner similar to that described for disodium cromoglycate.[Abstract] [Full Text] [Related] [New Search]